Инфекционные болезни
1511 статей · 54 журналов
Журналы подкатегории (54)
- Clinical Infection in Practice · Elsevier (80)
- Clinical Microbiology and Infection · Elsevier (80)
- Journal of Migration and Health · Elsevier (79)
- IDCases · Elsevier (77)
- Infection Prevention in Practice · Elsevier (77)
- Journal of Hospital Infection · Elsevier (77)
- New Microbes and New Infections · Elsevier (74)
- The Lancet Infectious Diseases · Elsevier (71)
- Journal of Infection and Chemotherapy · Elsevier (69)
- Tropical Medicine and International Health · Wiley (63)
- Journal of Microbiology, Immunology and Infection · Elsevier (62)
- Acta Tropica · Elsevier (57)
- Indian Journal of Tuberculosis · Elsevier (52)
- Diagnostic Microbiology and Infectious Disease · Elsevier (46)
- Hepatology Research · Wiley (44)
- Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Elsevier (43)
- Anaerobe · Elsevier (39)
- Infection, Disease & Health · Elsevier (37)
- Microbial Risk Analysis · Elsevier (36)
- The Lancet HIV · Elsevier (35)
- Journal of Clinical Virology · Elsevier (34)
- Ticks and Tick-borne Diseases · Elsevier (34)
- Biosafety and Health · Elsevier (30)
- Transplant Infectious Disease · Wiley (28)
- Travel Medicine and Infectious Disease · Elsevier (28)
- Journal of Medical Virology · Wiley (22)
- Infectious Diseases Now · Elsevier (21)
- Spatial and Spatio-temporal Epidemiology · Elsevier (19)
- Vacunas · Elsevier (18)
- Zoonoses and Public Health · Wiley (18)
- Reviews in Medical Virology · Wiley (17)
- Influenza and other Respiratory Viruses · Wiley (13)
- Clinical Microbiology Newsletter · Elsevier (8)
- The Brazilian Journal of Infectious Diseases · Elsevier (8)
- Mycoses · Wiley (7)
- Journal of the International AIDS Society · Wiley (5)
- Helicobacter · Wiley (3)
- AIDS and Behavior · Springer Nature (0)
- Annals of Clinical Microbiology and Antimicrobials · Springer Nature (0)
- BMC Infectious Diseases · Springer Nature (0)
- Current Fungal Infection Reports · Springer Nature (0)
- Current HIV/AIDS Reports · Springer Nature (0)
- Current Infectious Disease Reports · Springer Nature (0)
- Current Tropical Medicine Reports · Springer Nature (0)
- Gut Pathogens · Springer Nature (0)
- Hepatology Research · Springer Nature (0)
- Infection · Springer Nature (0)
- Journal of Ophthalmic Inflammation and Infection · Springer Nature (0)
- Malaria Journal · Springer Nature (0)
- Parasitology Research · Springer Nature (0)
- Retrovirology · Springer Nature (0)
- Tropical Diseases, Travel Medicine and Vaccines · Springer Nature (0)
- Tropical Medicine and Health · Springer Nature (0)
- Virology Journal · Springer Nature (0)
- Reinforced strategies versus standard pneumococcal vaccination regimen in patients with ANCA-associated vasculitides receiving rituximab therapy: A Multicenter Randomized Controlled Trial
- Artificial Intelligence for sepsis prediction: A review of real-world clinical implementation
- Re: ‘Hepatitis delta in Spain: a nationwide prospective characterization of active infection and liver disease severity’ by Alberola et al.
- Hepatitis B after switch to long-acting cabotegravir/rilpivirine: data from the SCohoLART cohort
- Optimising posaconazole dosing in paediatric patients: a population pharmacokinetic modelling and simulation study
- Which trial do we need? RSV booster vaccination in immunocompromised patients: Immunogenicity, safety and efficacy of booster vaccination strategies – Boost or bypass?
- Tailored Dosing Recommendations for Amikacin in Severely Ill Children: A Population Pharmacokinetic–Pharmacodynamic Evaluation using Cmax/MIC and AUC/MIC-based Indices
- Are systemic breakpoints appropriate for ocular infections?
- Machine learning for small-molecule antibiotics – discovery to pre-clinical optimization
- Model-informed dosing strategies for inhaled aminoglycosides in nosocomial pneumonia
- IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial
- Audit of imported malaria cases in a low-incidence region: Timeliness of therapy and adherence to treatment standards in NHS Lothian, Scotland (2023–2025)
- Umbilical cord-derived mesenchymal stromal cells for COVID-19 ARDS: a phase 1 case series
- Antimicrobial resistance in fragile health systems: why Somalia cannot afford to ignore the silent pandemic
- Tuberculosis in Somalia: A preventable crisis in a fragile state
- Rain brings malaria: Somalia's wet season fuels another preventable health crisis
- Bundibugyo virus disease in outbreak settings: A practical clinical review
- Cholera in Somalia: A preventable catastrophe demanding clinical and public health action
- Suspected plague, unconfirmed infection: Lessons in laboratory biosafety and public health preparedness
- Genomic surveillance and evolutionary dynamics of SARS-CoV-2 variants in Yunnan, China, 2022–2025
- Hantavirus outbreak on a cruise ship: Public health challenges
- The first key for the Priority Pathogens: Protective immunogens in development of vaccines and medications
- Current status and prospects in diagnosis of major opportunistic fungal infections among HIV-positive population in south provinces of China and neighboring countries that are suffering high prevalence of AIDS
- Systematic optimization of a domestic nose-only aerosol exposure system for respiratory pathogen research in nonhuman primates
- Escalating trends and burden of HIV among men who have sex with men in Bangladesh: A newly emerging concentrated epidemic
- Receptor-mimicking antibodies retain neutralization of recent SARS-CoV-2 variants
- Computational biology and bioinformatics for infectious disease research: From molecular mechanisms to population-level surveillance
- Live-attenuated vaccines of human respiratory syncytial virus for infants and young children: Progress and prospects of an old yet promising platform
- The 2026 MV Hondius Andes virus outbreak: Implications for hantavirus research, vaccine development, and biosecurity
- Deciphering the virus-host dialogue: Progress and prospects of AI-powered single-cell and spatial multi-omics in analyzing the hepatitis B immune microenvironment